Cloning, Sequencing, and Expression in Escherichia coli of lcnB, a Third Bacteriocin Determinant from the Lactococcal Bacteriocin Plasmid p9B4-6 by Belkum, Marco J. van et al.
  
 University of Groningen
Cloning, Sequencing, and Expression in Escherichia coli of lcnB, a Third Bacteriocin
Determinant from the Lactococcal Bacteriocin Plasmid p9B4-6
Belkum, Marco J. van; Kok, Jan; Venema, Gerhardus
Published in:
Applied and environmental microbiology
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1992
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Belkum, M. J. V., Kok, J., & Venema, G. (1992). Cloning, Sequencing, and Expression in Escherichia coli of
lcnB, a Third Bacteriocin Determinant from the Lactococcal Bacteriocin Plasmid p9B4-6. Applied and
environmental microbiology, 58(2), 572-577.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Vol. 58, No. 2APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Feb. 1992, p. 572-577
0099-2240/92/020572-06$02.00/0
Copyright C) 1992, American Society for Microbiology
Cloning, Sequencing, and Expression in Escherichia coli of lcnB,
a Third Bacteriocin Determinant from the Lactococcal
Bacteriocin Plasmid p9B4-6
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On the bacteriocin plasmid p9B4-6 of Lactococcus lactis subsp. cremoris 9B4, a third bacteriocin determinant
was identified. The genes encoding bacteriocin production and immunity resided on a 1.2-kb Celll-ScaI
fragment and were located adjacent to one of two previously identified bacteriocin operons (M. J. van Belkum,
B. J. Hayema, R. E. Jeeninga, J. Kok, and G. Venema, Appl. Environ. Microbiol. 57:492-498, 1991). The
fragment was sequenced and analyzed by deletion and mutation analyses. The bacteriocin determinant
consisted of two genes which were transcribed as an operon. The first gene (lcnB), containing 68 codons, was
involved in bacteriocin activity. The second gene (lciB) contained 91 codons and was responsible for immunity.
The specificity of this novel bacteriocin, designated lactococcin B, was different from that of the other two
bacteriocins specified by p9B4-6. Part of the nucleotide sequence of the lactococcin B operon was similar to a
nucleotide sequence also found in the two other bacteriocin operons of p9B4-6. This conserved region
encompassed a nucleotide sequence upstream of the bacteriocin gene and the 5' part of the gene. When the
lactococcin B operon was expressed in Escherichia coli by using a T7 RNA polymerase-specific promoter,
antagonistic activity could be detected.
Lactic acid bacteria produce a variety of substances with
antimicrobial activity which are of potential interest for food
fermentation and preservation. In many cases, it has been
shown that the compounds responsible for antagonistic
activity, termed bacteriocins, were of a proteinaceous nature
(16). Although numerous reports on the detection and bio-
chemical characterization of bacteriocins produced by lactic
acid bacteria are available, knowledge concerning their
genetics is scarce. The genetic determinants for bacteriocin
activity were shown to be plasmid encoded in several
species (7, 8, 15, 22, 24, 25, 29), whereas other members of
the lactic acid bacteria carried the bacteriocin genes on their
chromosomes (1, 9, 13, 34). A number of bacteriocin deter-
minants have recently been cloned. Scherwitz-Harmon and
McKay (29) located the bacteriocin determinants of Lacto-
coccus lactis subsp. lactis WM4 on two BclI fragments from
the 88-MDa plasmid pNP2. The structural genes of helveti-
cin J from Lactobacillus helveticus 481 and lactacin F from
Lactobacillus acidophilus 11088 have been cloned and se-
quenced (14, 24). Additionally, the structural gene for pre-
nisin has been cloned and sequenced from a number of
lactococcal strains (4, 9, 15).
The genetic determinants for bacteriocin production and
immunity in L. lactis subsp. cremoris 9B4 are located on the
60-kb conjugative plasmid p9B4-6 (25). From this plasmid,
two fragments were cloned, each of which specified bacte-
riocin activity as well as immunity (35). A 1.8-kb ScaI-ClaI
fragment (contained in pMB225) specified low antagonistic
activity, whereas the other, a 1.3-kb ScaI-HindIII fragment
(present in pMB553), encoded high antagonistic activity.
Sequence and mutation analyses (36) showed that the 1.8-kb
fragment contained three open reading frames (ORFs); the
first two (ORF-A1 and -A2) were involved in bacteriocin
production, whereas the third (ORF-A3) was involved in
* Corresponding author.
immunity. On the insert in pMB553, two ORFs were identi-
fied; the first one (ORF-B1) was responsible for bacteriocin
activity, and the second (ORF-B2) specified immunity. On
both fragments, the ORFs were organized in an operon. The
specificities of the two bacteriocins were different. Recently,
Holo et al. (12) have purified a bacteriocin, designated
lactococcin A, from a strain of L. lactis subsp. cremoris and
determined its amino acid sequence. The bacteriocin struc-
tural gene was cloned and sequenced with synthetic oligo-
nucleotides. It appeared that the sequence was identical to
the sequence of ORF-B1 of pMB553 and that the N-terminal
part of the polypeptide specified by this ORF is cleaved off to
give the mature bacteriocin molecule. To prevent confusion,
we decided to rename ORF-B1 (the structural gene for
lactococcin A) and -B2 (specifying immunity towards lacto-
coccin A) IcnA and IciA, respectively. ORF-A1, -A2 (spec-
ifying a different type of bacteriocin activity), and -A3
(specifying the corresponding immunity) of pMB225 will
now be designated IcnM, IcnN, and IciM, respectively. The
bacteriocin specified by this plasmid will be designated
lactococcin M.
Here we report on the cloning and sequencing of a third
bacteriocin determinant of p9B4-6, specifying a bacteriocin
designated lactococcin B, and show that the genes involved
in bacteriocin production and immunity are also in this case
transcribed as an operon. Using the T7 RNA polymerase-
specific promoter for transcription of this operon in Esche-
richia coli, we were able to detect antagonistic activity by
this host against sensitive lactococcal strains.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The bacterial
strains and plasmids used are listed in Table 1. E. coli was
grown in TY broth (26) and plated on TY agar medium.
Glucose-M17 broth (33) and glucose-M17 agar were used to
culture L. lactis. Selective concentrations of kanamycin,
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TABLE 1. Bacterial strains and plasmids
Strain or plasmid Descriptiona Reference
Strains
E. coli
MH1 MC1061 derivative; 5
araD139 lacX74 galU
galK hsr hsm+ strA
BL21(DE3) F- ompT rB- mB- int; 31
bacteriophage DE3




L. lactis subsp. Plasmid free 6
lactis IL1403
Plasmids
pT712 Ampr, 2.8 kb; T7- 32
polymerase expression
vector
pMB225 Emr, 6.2 kb; specifying 35
lactococcin M
pMB553 Emr, 5.1 kb; specifying 35
lactococcin A
pMB500 Kmr, 18.2 kb; specifying 35
lactococcin A and B
pGKV210 Emr, 4.4 kb 38
pMB510 Kmr, 16.1 kb This study
pMB570 Emr, 6.5 kb; specifying This study
lactococcin A and B
pMB580 Emr, 5.6 kb; LcnB+, LciB+ This study
pMB581 Emr, 5.6 kb; LcnB+, LciB- This study
pMB582 Emr, 4.6 kb; LcnB, LciB- This study
pMB583 Emr, 5.6 kb; LcnB- LciB+ This study
pMB585 Emr, 5.5 kb; LcnB-, LciB+ This study
pT580 Ampr, 3.8 kb This study
pT585 Ampr, 3.7 kb This study
a LcnB+, producing lactococcin B; LcnB-, not producing lactococcin B;
LciB- and LciB+, sensitivity and immunity to lactococcin B, respectively;
Ampr, Emr, and Cmr, resistance to ampicillin, erythromycin, and chloram-
phenicol, respectively.
erythromycin, and ampicillin used for E. coli were 50, 100,
and 50 p.g/ml, respectively. For L. lactis, kanamycin and
erythromycin were used at final concentrations of 50 and 5
,ug/ml, respectively.
Molecular cloning and DNA sequence analysis. Isolation of
plasmid DNA from E. coli was done as described by
Birnboim and Doly (3). With some modifications (37), the
same method was used to isolate plasmid DNA from L.
lactis. Restriction enzymes, the Klenow fragment of E. coli
DNA polymerase I, and T4 DNA ligase were obtained from
Boehringer (Mannheim, Germany) and were used according
to the instructions of the supplier. DNA cloning and manip-
ulation techniques were carried out essentially as described
by Maniatis et al. (20). E. coli cells were made competent
and were transformed by the method of Mandel and Higa
(19). Electrotransformation of L. lactis was carried out as
described by Leenhouts et al. (18), using a Bio-Rad gene
pulser (Bio-Rad Laboratories, Richmond, Calif.). Nucleo-
tide sequence analysis was performed by sequencing double-
stranded DNA in two orientations by the dideoxy-chain
method of Sanger et al. (27), using the T7 sequencing kit
(Pharmacia, Uppsala, Sweden).
MicroGenie software (Beckman, Palo Alto, Calif.) was
used to identify restriction sites in the nucleotide sequence.
DNA was amplified with Taq DNA polymerase (Promega,
Madison, Wis.) by using a Bio-med thermocycler 60 (B.
Braun, Melsungen, Germany). Synthetic oligonucleotides
for sequencing and DNA amplification were made with an
Applied Biosystems 381A DNA synthesizer (Applied Bio-
systems, Foster City, Calif.). A deletion primer of 56 resi-
dues (5'-TATATGGTCCAGCACTCATAACATACTGCAA
GCTCATAATAATCTCCTTATTTTTA-3'), complemen-
tary to residues 332 to 353 and 414 to 447 of the DNA
sequence (see Fig. 2), together with a 17-mer primer (5'-
TTCAAAGTCTACCCTGA-3') complementary to a se-
quence in the noncoding strand upstream of the multiple
cloning site of pMB580, were used for DNA amplification
with pMB580 as template.
Bacteriocin assay. Screening of L. lactis transformants for
bacteriocin activity has been described previously (35). L.
lactis IL1403 was used as the indicator strain.
T7 RNA polymerase-directed expression in E. coli. A cul-
ture of E. coli BL21(DE3) was grown to an optical density at
600 nm of 0.3 and subsequently induced for expression of the
T7 RNA polymerase gene by the addition of isopropyl-p-D-
thiogalactopyranoside (IPTG; final concentration, 0.4 mM).
After 1 h of incubation at 37°C, rifampin was added to a final
concentration of 200 pg/ml. After an additional incubation of
1 h, cells were collected by centrifugation, concentrated
25-fold in sample buffer (62.5 mM Tris-HCl [pH 6.8]), 17.5%
[vol/vol] glycerol, 2% [wt/vol] sodium dodecyl sulfate [SDS],
5% [vol/vol] P-mercaptoethanol, and 0.006% bromophenol
blue), heated to 100°C for 10 min, and subjected to poly-
acrylamide gel electrophoresis (PAGE) (30).
Assay for bacteriocin activity in tricine-SDS-polyacrylamide
gels. Samples (20 [lI) of cell extract (equivalent to 500 RI of
cell culture) were subjected to tricine-SDS-PAGE (28) by
using a Bio-Rad mini-protean II (Bio-Rad). The composi-
tions of the stacking gel and the spacer gel were as described
by Schagger and von Jagow (28). The separating gel con-
tained a mixture of 16% (wt/vol) acrylamide and 0.5%
(wt/vol) bisacrylamide (28). After electrophoresis, the gel
was fixed in 20% isopropanol and 10% acetic acid and
washed in deionized water as described by Bhunia et al. (2).
The gel was subsequently placed on a glucose-M17 agar
plate. After 15 min, an overlayer of 4 ml of soft glucose-M17
agar (0.7%), containing 100 ,ul of an overnight culture of L.
lactis IL1403 as an indicator, was poured on the surface of
the agar plate. After 15 h of incubation at 30°C, the plate was
examined for zones of inhibition of growth. As a reference,
12.5 ,ul of the supernatant of a bacteriocin-producing late-
exponential-phase culture of L. lactis, mixed in a 1:1 ratio
with 2x sample buffer (30), was also applied to the gel.
RESULTS
Identification of a novel bacteriocin determinant on p9B4-6.
As reported previously (36), preliminary sequence analysis
showed that downstream of the bacteriocin operon on the
1.3-kb Scal-HindIII fragment of pMB553 (Fig. 1) a sequence
was present which was similar to the identical nucleotide
sequences found upstream of the two bacteriocin operons of
p9B4-6. This observation prompted us to investigate
whether a third bacteriocin determinant, interrupted by the
HindIll site on the 3' end of the 1.3-kb ScaI-HindIII frag-
ment, was present downstream of the lactococcin A operon.
The region downstream of the 1.3-kb fragment was obtained
by cloning a 2.1-kb Scal fragment from pMB500 into the
SmaI site of the pWV01-derived (17) shuttle vector
pGKV210, giving plasmid pMB570 (Fig. 1). L. lactis IL1403
containing this plasmid inhibited the growth of IL1403
VOL. 58, 1992
















FIG. 1. Schematic representation of the insert in pMB500 and its derivatives. Only restriction enzyme sites relevant for the construction
of the various subclones are shown. The arrows indicate the locations and the directions of transcription of the two bacteriocin operons
present on pMB570. The part of the 2.1-kb ScaI fragment sequenced previously (36) is represented by the open bar. The sizes of the cloned
fragments are indicated on the right.
(pMB553), but IL1403(pMB553) did not inhibit the growth of
IL1403(pMB570). When IL1403 was used as the indicator
strain, the size of the halo produced by IL1403(pMB570) was
comparable to that produced by IL1403(pMB553) but some-
what reduced compared with that produced by IL1403
containing pMB500 (results not shown). When the 2.1-kb
Scal fragment was deleted from pMB500, resulting in plas-
mid pMB510 (Fig. 1), no antagonistic activity by L. lactis
could be detected. The 2.1-kb Scal fragment contains a
unique CelII site which was used to delete a 0.9-kb Scal-
CelII fragment carrying the lactococcin A operon. L. lactis
IL1403 carrying the resulting plasmid, pMB580 (Fig. 1),
inhibited the growth of IL1403(pMB225) and IL1403
(pMB553) but was sensitive to the pMB225- and pMB553-
specified bacteriocins. Apparently, we had succeeded in
cloning a novel bacteriocin determinant that specified lacto-
coccin B with a specificity different from that of the other
two bacteriocins of p9B4-6.
Nucleotide sequence of the lactococcin B operon. The nu-
cleotide sequence of the lactococcin B determinant present
on the 2.1-kb Scal fragment is shown in Fig. 2. Downstream
of IciA, two ORFs were identified which could encode
polypeptides of 68 and 91 amino acids, respectively. Both
ORFs were preceded by a putative ribosome-binding site.
An inverted repeat found 34 bp downstream of the TAA stop
codon of the second ORF could act as a rho-independent
terminator. The potential stem-and-loop structure had a AG
of -82 kJ/mol. A stretch of 123 bp immediately upstream of
the first ORF appeared to be almost identical to the nucleo-
tide sequences upstream of the two other bacteriocin deter-
minants of p9B4-6 (36), and therefore, the promoter se-
quences of the three bacteriocin operons are most probably
identical (Fig. 2). Furthermore, the 5' nucleotide sequence of
the first ORF was identical to the first 20 bp of lcnM and
almost identical to the first 64 bp of IcnA. No further
nucleotide sequence similarity between the three bacteriocin
operons could be found. The amino acid sequences deduced
from both ORFs were compared with the deduced amino
acid sequences from the genes of the two previously identi-
fied bacteriocin determinants of p9B4-6. Significant homol-
ogy was found only between the N-terminal 21 amino acids
of the polypeptides specified by the first ORF, 1cnA, and
lcnM (Fig. 3).
The lactococcin B operon contains genes for bacteriocin
production and immunity. Both ORFs on the insert in
pMB580 were subjected to in vitro deletion and mutagenesis.
The mutated plasmid derivatives were isolated from E. coli
MH1 and transferred to L. lactis IL1403, and the transfor-
mants were screened for bacteriocin production and immu-
nity. Figure 4 shows the properties of the various pMB580
derivatives. Filling in the Avall site with Klenow DNA
polymerase resulted in the addition of an extra amino acid
residue (Arg) between Gly-30 and Pro-31 in the first ORF
(yielding plasmid pMB583). L. lactis cells containing this
plasmid showed a Bac- Imm+ phenotype, which indicates
that the first ORF, designated lcnB, is involved in bacterio-
cin production. Removal of the promoter region and the 5'
part of IcnB by deleting the 0.31-kb CelII-HindIII fragment
of pMB580 (pMB582) resulted in loss of bacteriocin activity
as well as immunity, suggesting that the second ORF is
involved in immunity and is transcribed from the same
promoter as IcnB. Transformation of L. lactis with pMB581,
which carries a frameshift mutation in the presumed immu-
nity gene, by filling in the BstNI site of the second ORF gave
rise to very small colonies of bacteriocin-producing transfor-
mants. When the growth medium was supplemented with
30% (vol/vol) supernatant of the bacteriocin-producing strain
IL1403(pMB580), no transformants could be detected on the
plates. Apparently, as was observed before (36), the initial
concentration of bacteriocin produced by L. lactis transfor-
mants carrying a nonfunctional immunity gene was too low
to completely inhibit the growth of the transformants. These
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stop lciA
TTCATTACAAGTTCCAAAGCATCAAACAAAAATAGTGGTGGTAATTATGTCG7GGACGACTATTCTAT^AATCAACAGAACT
F I T S S K A S N K N L G G G L I N S W G R L P
AATAAAAGAATGCTGAgGCAAATTACGCCATTCTTATTAGTTAAGTGCCATGCTAAAAAGAGACGTGCCATTGATTAAGCA
AAGACATTCGATCG AAT4MTTATCGAATTCTCT1 S .AATTACTTTTFMATAAAATAA7GAAGAGGCAAT
-35nI -10 rbs start lcnB
CAGTAGAGTGTTAATAT1T_TAACGAGMTTTIATFTATATATCTATAATMA=ATAAATT ATTATGAAAAATCA--~~~lK N Q
*~~ ~~~~~UnL. .. TTY
ATTAaTTTAaATTTTTTGAGAAAaCTGCGAATTATGGAGGAWCTTGCAGTATGTTATGAGTGCTGGACCATATACTTG
L N F N I V S D E E L A E V N G G P L Q Y V N S A G P Y T W
GTATAAAGATACTAGAACAGGAAAKACAATAIGTAAACAGACAATIGACACAGCAAGTTATACATTFGGVGTAAMGGCAGAAGGA;GGGY K D T R T G K T I C K Q T I D T A S Y T F G V t A E G W G
stop lcnB rbs start lciB
AAAAACATTCCACTAATAAAAAAAACTGGTTTGAGTTAATGAAAAAAAATTGATACAAAAAACAAATTACIACTTGGGCATCT
K T P H N K X R V D T E K Q I T S W A S
GACTTAGCTTCCKANA TGTTCAAG YAAATTAATACTGTC ACATCGQ IAACCAGTVCTTTCCA
D L A S 1K N E T K V Q E K L I L S S Y I Q D I E N B V Y F P
AAAGCAAA1TrMAAAAAAAATTACGAGACCAAAATAATATTTGCGCT rATCAAAAGATCAATCAGTTTTATTTTAAAGTT
K A M I S L E R K L R D Q N N I C A L S K E V N Q F Y F K V
G= stop lciB
GTTGATAAATCAAAGAAATCCTGGATGGTAGGTTIGATATTTAATTATCTCAGAIrATTGATTCTATTAAGAAGCTCCTT

















TTATGTTA1ATACAATACAACAAGTCCTTTAGAA ATATGACGTA A TT7ACMAWTACT 1260
FIG. 2. Nucleotide and deduced amino acid sequences of a 1,260-bp segment of pMB570. The deduced amino acid sequences of IcnB, IciB,
and the C-terminal part of IciA are shown below the nucleotide sequence. The putative -35 and -10 regions of the promoter as well as the
putative ribosome-binding sites (rbs) of IcnB and IciB are indicated. The inverted repeats downstream of lciA and lciB are underlined by solid
arrows. Restriction enzyme sites used for mutagenesis are indicated. The region between the two vertical arrows below the DNA sequence
represents the region of similarity of the nucleotide sequence upstream of lcnB and the 5' part of lcnB with the sequence upstream of IcnA
and the 5' part of lcnA. Mismatches are represented by dots above the nucleotide sequence. The two broken lines represent the sequence of
the deletion primer used to remove the intervening sequence by polymerase chain reaction.
Lactococcin B production in E. coli. As reported for the
two other bacteriocins of p9B4-6 (35), no antagonistic activ-
ity of lactococcin B in cells or lysates of E. coli(pMB580)
could be observed. In an attempt to express lactococcin B
in E. coli, the bacteriocin operon of pMB580 was introduced
into the E. coli expression vector pT712. The 0.97-kb
HindII-EcoRI fragment of pMB580 (the Scal site was lost as
a consequence of the cloning, and therefore, the EcoRI site
of the multiple cloning site was used) was cloned between
the Hindll and EcoRI sites of pT712. As the HindII site is
located between the -35 and -10 regions (Fig. 2), this
disrupted the promoter of the bacteriocin operon. In the
resulting plasmid, pT580, the bacteriocin operon was placed
under control of the T7 RNA polymerase-specific promoter.
After induction of the T7 RNA polymerase gene, samples of
lcnM M K N Q LUNRFIS EELQ G I N G G I R G T G K
lcnA N K N Q L NF N I V S D E E L S A N G G K L T F I Q
lcnB K N Q L N F N I V S D E E L A EVNGGSLSLQYVM
FIG. 3. Homology comparison of the N-terminal parts of the
deduced amino acid sequences of lcnM, IcnA, and lcnB. Identical
amino acids are boxed. The arrow indicates the processing site in
the lactococcin A precursor as determined by Holo et al. (12).
E. coli BL21(DE3) carrying pT580 were subjected to tricine-
SDS-PAGE and subsequently examined for bacteriocin ac-
tivity. At a position corresponding to about 6.5 kDa, a zone
of inhibition of growth that was absent in samples of E. coli
BL21(DE3) containing pT712 was observed (Fig. 5). The
zone of inhibition produced by a sample of the supernatant
of a culture of IL1403(pMB580) was found at a position
corresponding to about 3.4 kDa (Fig. 5). Apparently, the size
of the lactococcin B molecule secreted by the L. lactis cells
is less than that of the polypeptide responsible for the
antagonistic activity in the E. coli extracts. No bacteriocin
activity in the supernatant of the E. coli culture containing
pT580 could be detected. An extract of E. coli BL21(DE3)
containing pMB580 did not give rise to antagonistic activity
on the gel (Fig. 5, lane 4). Holo et al. (12) have shown that
the bacteriocin encoded by lcnA is synthesized as a precur-
sor of 75 amino acids and is processed by removal of the
N-terminal 21 amino acids. As shown in Fig. 4, the first 21
amino acids of the IcnM, IcnA, and IcnB products are nearly
identical, which strongly suggests that these polypeptides
are processed at the same position. This assumption seems
to be confirmed by the fact that lactococcin A, with a
precursor almost equal in size to the polypeptide specified by
IcnB, migrates to the same position on the gel as lactococcin
B (36). To examine whether the absence of the N-terminal
X3TILk.MC.TTCT.TTTATCTTGATTTAAAAACAATGAGAATGAAAATGTTTGGAGAAAAGAAAGATTAATTGACTGAAATGTAAAAAC
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FIG. 4. Phenotype of various mutation deriv,
The restriction enzyme map and location of lcn
1.2-kb CelII-ScaI fragment of pMB580 are show
sent the parts of the 1.2-kb fragment present ii
clones. Asterisks indicate mutations in the ORI
text). The arrow indicates the direction of transcr
production (Bac) and immunity (Imm) expressi
clones are indicated. The open box represents
from lcnB by polymerase chain reaction.
part, which is apparently removed in L. lact
on lactococcin B activity, the DNA se(
nucleotides 353 and 414 was deleted from 1
ase chain reaction (see Materials and Metl
merase chain reaction product was digeste
AvaIl and used to replace the PstI-Av
pMB580, giving pMB585 (Fig. 4). This plasn
expected deletion endpoints, as judged b
quence analysis. L. lactis cells containin,
normally and were Bac- Imm+. When the
EcoRI fragment of pMB585 was cloned in p'
E. coli BL21(DE3) containing the resulting
did not give rise to antagonistic activity a
tricine-SDS-PAGE (results not shown).
DISCUSSION
The work presented here describes the i
molecular analysis of the genetic determina
B, a bacteriocin with a specificity different
FIG. 5. Detection of bacteriocin activity in a
acrylamide gel by the overlay test. Lanes: 1, 3, a
coli BL21(DE3) containing pT580, pT712, and
tively; lane 2, supernatant of L. lactis IL1403 cc
lane 5, molecular size standard (Rainbow proteir
marker; Amersham International, Amersham, Ei
sizes (in kilodaltons) are shown on the right.
bacteriocins specified by the two previously cloned bacteri-
ocin determinants of p9B4-6 (35).
Imm wmid We have reported previously that L. lactis cells containingpMB500 showed a higher level of bacteriocin activity than L.
+ + pMB580 lactis cells carrying pMB553 (35). A subclone (pMB570)
carrying the 2.1-kb ScaI fragment of pMB500 had a level of
- + pMB583 bacteriocin activity still less than that of pMB500. Inhibition
studies with pMB510 showed that no further bacteriocin
-
- pMB582 determinants were present on the 15-kb fragment. Appar-
ently, some other information on pMB500 is responsible for
+ - pMB581 optimal expression of the bacteriocin phenotype.
+ pMB585 The reason why the nucleotide regions upstream of thegenes of the bacteriocin operons and also the 5' ends of the
atives of pMB580. first genes of these operons are similar is as yet unclear.
iB and lciB on the Preliminary results indicate that immediately upstream of
n. The lines repre- the promoter regions of the lactococcin M and A operons,
n the various sub- the 3' end of an ORF is present. The fact that the three
Fs (for details, see bacteriocin operons are linked to similar DNA regions may
,ed by the various suggest that their combined presence on p9B4-6 is the result
the region deleted of recombinational events, thus providing the organism with
a selective advantage in a competitive environment with
other bacteriocin-producing lactococci.
Previous experiments to express bacteriocin activity in E.
is, had any effect coli were unsuccessful (35). Attempts to express bacteriocin
quence between activity in E. coli also failed for helveticin J (14) and for the
IcnB by polymer- bacteriocin BCN5 of Clostridium perfringens (10). In bothhods). The poly- studies, it was suggested that the high A+T content of thehd with PstI and genes involved was responsible for the lack of expression, as
-II fragment of codons rich in A and T are infrequently used in E. coli. Using
aid contained the the T7 polymerase-specific promoter, we were able to detect
y nucleotide se- antagonistic activity with the pMB580-specified bacteriocin
g pMB585 grew in E. coli. The finding that the lcnA product is processed by0.91-kb Hindg- removal of the 21-amino-acid N terminus (12) and the fact
T712, extracts of that this N terminus is similar to the N termini of the lcnM
construct pT585 and IcnB products strongly suggest that the polypeptides
s determined by encoded by lcnM, IcnA, and lcnB are processed in anidentical way in L. lactis. The difference in molecular size
between the bacteriocin present in the L. lactis supernatant
and the protein responsible for antagonistic activity in the E.
coli extract may be explained by assuming that E. coli is
dentification and unable to process the bacteriocin precursor. Deletion of theentoflactococcinan 5' part of lcnB to obtain the mature-sized bacteriocin as thent of lactococcin primary translation product did not result in activity in cells
from that of the or lysates of L. lactis and E. coli. Either the truncated gene
is poorly expressed or the N-terminal part is essential to get
an active product. The molecular size of the primary trans-
lation product specified by lcnB is 7.6 kDa. After deletion of
its 21 N-terminal amino acids, postulated on the basis of the
similarity to lactococcin A, the mature product would be 5.3
kDa. The discrepancy between these values and the molec-
ular sizes determined by tricine-SDS-PAGE is probably due
to the hydrophobic nature of the polypeptide specified by
IcnB. Muriana and Klaenhammer (23) observed a similar
difference between the molecular size deduced from SDS-
PAGE and that determined from the amino acid composition
of the purified bacteriocin lactacin F.
Recently, the bacteriocin pediococcin PA-1 from Pedio-
coccus acidilactici PAC 1.0 was purified and its amino acid
sequence was determined (11, 21). Subsequently, the bacte-
.tricine.SDSpoly riocin structural gene was cloned and sequenced, and it wastriclne-SDS-poly- shown that the bacteriocin molecule was synthesized as a
LpMB580, respec- precursor of 62 amino acids. An N-terminal sequence con-
Dntaining pMB580- sisting of 18 amino acids was removed to yield the mature
n molecular weight bacteriocin molecule. The cleavage occurred on the C-ter-
ngland); molecular minal side of two adjacent glycine residues (21). Lactacin F
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amino acids (24). Also in this case, cleavage occurred at the
C-terminal side of two glycine residues, resulting in the
formation of a mature peptide of 57 amino acids (24). As is
shown in Fig. 3, a similar cleavage site behind two glycine
residues was also found in the precursor of lactococcin A,
and on the basis of similarity between their N termini, most
probably this also applies to the lactococcin B and M
precursors. Thus, it would seem that a common cleavage site
is used in lactic acid bacteria and that a similar processing
mechanism underlies maturation of a variety of small hydro-
phobic bacteriocins in these organisms.
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